Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/bcr2590.

Title:
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns | Breast Cancer Research
Description:
Introduction Five different molecular subtypes of breast cancer have been identified through gene expression profiling. Each subtype has a characteristic expression pattern suggested to partly depend on cellular origin. We aimed to investigate whether the molecular subtypes also display distinct methylation profiles. Methods We analysed methylation status of 807 cancer-related genes in 189 fresh frozen primary breast tumours and four normal breast tissue samples using an array-based methylation assay. Results Unsupervised analysis revealed three groups of breast cancer with characteristic methylation patterns. The three groups were associated with the luminal A, luminal B and basal-like molecular subtypes of breast cancer, respectively, whereas cancers of the HER2-enriched and normal-like subtypes were distributed among the three groups. The methylation frequencies were significantly different between subtypes, with luminal B and basal-like tumours being most and least frequently methylated, respectively. Moreover, targets of the polycomb repressor complex in breast cancer and embryonic stem cells were more methylated in luminal B tumours than in other tumours. BRCA2-mutated tumours had a particularly high degree of methylation. Finally, by utilizing gene expression data, we observed that a large fraction of genes reported as having subtype-specific expression patterns might be regulated through methylation. Conclusions We have found that breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles. Our results suggest that methylation may play an important role in the development of breast cancers.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Movies

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

tumours, methylation, genes, expression, cancer, breast, prc, gene, pubmed, basallike, subtypes, article, cells, lumb, google, scholar, levels, targets, data, methylated, cell, figure, luminal, cpg, cas, molecular, set, relative, found, dna, analysis, subtype, target, ezh, file, patterns, tumour, central, cpgs, sites, additional, low, luma, cluster, samples, results, average, identified, status, calculated,

Topics {✒️}

free open-source system gene hypermethylation profile embryonic ectoderm development mda-mb-231 hotair cells high-resolution genomic profiles large b-cell lymphomas cell-type specific manner cell-type-specific manner capillary-array electrophoresis analysis article download pdf subtype-specific methylation revealed subtype-specific methylation patterns luminal subtype-specific markers full size image subtype-specific expression patterns higher s-phase fractions subtype-characteristic expression patterns array-based methylation assay display genomic profiles her2-positive breast cancer prc2-mediated gene silencing author information authors stem/progenitor cells highest s-phase fractions markus ringnér her2-amplified breast cancer mda-mb-231 cells k-means clustering results translational cancer research predominantly er-negative tumours lymph node-positive tumours s-phase fraction highest significant subtype-specific cpgs lymph node-negative tumours strategic research full access higher methylation frequency primary breast tumors differentiated luminal cell gene expression omnibus privacy choices/manage cookies her2-enriched molecular subtypes high methylation frequency average methylation frequency polycomb-mediated methylation characteristic methylation patterns cancer cell lines luminal tumour tissue swedish research council article number r36

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
         description:Five different molecular subtypes of breast cancer have been identified through gene expression profiling. Each subtype has a characteristic expression pattern suggested to partly depend on cellular origin. We aimed to investigate whether the molecular subtypes also display distinct methylation profiles. We analysed methylation status of 807 cancer-related genes in 189 fresh frozen primary breast tumours and four normal breast tissue samples using an array-based methylation assay. Unsupervised analysis revealed three groups of breast cancer with characteristic methylation patterns. The three groups were associated with the luminal A, luminal B and basal-like molecular subtypes of breast cancer, respectively, whereas cancers of the HER2-enriched and normal-like subtypes were distributed among the three groups. The methylation frequencies were significantly different between subtypes, with luminal B and basal-like tumours being most and least frequently methylated, respectively. Moreover, targets of the polycomb repressor complex in breast cancer and embryonic stem cells were more methylated in luminal B tumours than in other tumours. BRCA2-mutated tumours had a particularly high degree of methylation. Finally, by utilizing gene expression data, we observed that a large fraction of genes reported as having subtype-specific expression patterns might be regulated through methylation. We have found that breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles. Our results suggest that methylation may play an important role in the development of breast cancers.
         datePublished:2010-06-18T00:00:00Z
         dateModified:2010-06-18T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/licenses/by/2.0/
         sameAs:https://doi.org/10.1186/bcr2590
         keywords:
            Molecular Subtype
            Methylation Frequency
            Luminal Tumour
            Luminal Progenitor
            Embryonic Ectoderm Development
            Cancer Research
            Oncology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig7_HTML.jpg
         isPartOf:
            name:Breast Cancer Research
            issn:
               1465-542X
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Karolina Holm
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cecilia Hegardt
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johan Staaf
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johan Vallon-Christersson
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Göran Jönsson
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Håkan Olsson
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Åke Borg
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Markus Ringnér
               affiliation:
                     name:Clinical Sciences, Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
      description:Five different molecular subtypes of breast cancer have been identified through gene expression profiling. Each subtype has a characteristic expression pattern suggested to partly depend on cellular origin. We aimed to investigate whether the molecular subtypes also display distinct methylation profiles. We analysed methylation status of 807 cancer-related genes in 189 fresh frozen primary breast tumours and four normal breast tissue samples using an array-based methylation assay. Unsupervised analysis revealed three groups of breast cancer with characteristic methylation patterns. The three groups were associated with the luminal A, luminal B and basal-like molecular subtypes of breast cancer, respectively, whereas cancers of the HER2-enriched and normal-like subtypes were distributed among the three groups. The methylation frequencies were significantly different between subtypes, with luminal B and basal-like tumours being most and least frequently methylated, respectively. Moreover, targets of the polycomb repressor complex in breast cancer and embryonic stem cells were more methylated in luminal B tumours than in other tumours. BRCA2-mutated tumours had a particularly high degree of methylation. Finally, by utilizing gene expression data, we observed that a large fraction of genes reported as having subtype-specific expression patterns might be regulated through methylation. We have found that breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles. Our results suggest that methylation may play an important role in the development of breast cancers.
      datePublished:2010-06-18T00:00:00Z
      dateModified:2010-06-18T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/licenses/by/2.0/
      sameAs:https://doi.org/10.1186/bcr2590
      keywords:
         Molecular Subtype
         Methylation Frequency
         Luminal Tumour
         Luminal Progenitor
         Embryonic Ectoderm Development
         Cancer Research
         Oncology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr2590/MediaObjects/13058_2009_2551_Fig7_HTML.jpg
      isPartOf:
         name:Breast Cancer Research
         issn:
            1465-542X
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Karolina Holm
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cecilia Hegardt
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johan Staaf
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johan Vallon-Christersson
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Göran Jönsson
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Håkan Olsson
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Åke Borg
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Markus Ringnér
            affiliation:
                  name:Clinical Sciences, Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research
      issn:
         1465-542X
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
         type:PostalAddress
      name:Clinical Sciences, Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Karolina Holm
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Cecilia Hegardt
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Johan Staaf
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Johan Vallon-Christersson
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Göran Jönsson
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Håkan Olsson
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Åke Borg
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Markus Ringnér
      affiliation:
            name:Clinical Sciences, Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden

External Links {🔗}(210)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📦}

  • Crossref
  • Pbgrd

4.94s.